Cargando…
Asymmetric Synthesis and Biological Screening of Quinoxaline-Containing Synthetic Lipoxin A(4) Mimetics (QNX-sLXms)
[Image: see text] Failure to resolve inflammation underlies many prevalent pathologies. Recent insights have identified lipid mediators, typified by lipoxins (LXs), as drivers of inflammation resolution, suggesting potential therapeutic benefit. We report the asymmetric preparation of novel quinoxal...
Autores principales: | de Gaetano, Monica, Tighe, Catherine, Gahan, Kevin, Zanetti, Andrea, Chen, Jianmin, Newson, Justine, Cacace, Antonino, Marai, Mariam, Gaffney, Andrew, Brennan, Eoin, Kantharidis, Phillip, Cooper, Mark E., Leroy, Xavier, Perretti, Mauro, Gilroy, Derek, Godson, Catherine, Guiry, Patrick J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279484/ https://www.ncbi.nlm.nih.gov/pubmed/34138563 http://dx.doi.org/10.1021/acs.jmedchem.1c00403 |
Ejemplares similares
-
Synthesis and
Biological Evaluation of Bicyclo[1.1.1]pentane-Containing
Aromatic Lipoxin A(4) Analogues
por: Owen, Benjamin, et al.
Publicado: (2022) -
QNX 4 operating systems : system architecture /
Publicado: (1992) -
Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function
por: Brennan, Eoin, et al.
Publicado: (2021) -
Lipoxin and Aspirin-Triggered Lipoxins
por: Romano, Mario
Publicado: (2010) -
Posing the rationale for synthetic lipoxin mimetics as an adjuvant treatment to gold standard atherosclerosis therapies
por: Millar, Braden, et al.
Publicado: (2023)